Clinical Studies

Initial Clinical Results:

Preliminary study results showed that 70% of the participants experienced a positive benefit from the use of the Iceotherm. This compares with a 40% efficacy rate of common drug treatment. A further review of the results led to the conclusion that the Iceotherm worked best on localized and chronic pain (defined as two months of identified pain), and had little or no effect on diffused and acute pain.

Current Clinical Trials:

The company has received approval from Health Canada for a Phase II clinical research trial on the Iceotherm commenced in the spring of 2008 at a major universtiy teaching hospital in Ontario. Up to eighty patients are involved in this study with the results expected in 2009.

Future Clinical Trials:

A Phase III placebo-controlled study is planned for 2009. To generate the placebo device the cold ceramic tile at the centre of the Iceotherm will be de-activated. It is believed that the cold sensation generated by the ceramic tile has the greatest effect on the relief of localized pain.